Breast Neoplasms

MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.

T. Zhang, Wan, J. G., Liu, J. B., and Deng, M., “MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.”, Genet Mol Res, vol. 16, no. 3, 2017.

Steroid metabolism gene polymorphisms and their implications on breast and ovarian cancer prognosis.

E. V. W. Dos Santos, Alves, L. N. R., and Louro, I. D., “Steroid metabolism gene polymorphisms and their implications on breast and ovarian cancer prognosis.”, Genet Mol Res, vol. 16, no. 3, 2017.

In vitro effects and mechanisms of lycopene in MCF-7 human breast cancer cells.

S. J. Peng, Li, J., Zhou, Y., Tuo, M., Qin, X. X., Yu, Q., Cheng, H., and Li, Y. M., “In vitro effects and mechanisms of lycopene in MCF-7 human breast cancer cells.”, Genet Mol Res, vol. 16, no. 2, 2017.

Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.

Y. Shen, Ye, Y. F., Ruan, L. W., Bao, L., Wu, M. W., and Zhou, Y., “Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.”, Genet Mol Res, vol. 16, no. 1, 2017.

Migration and invasion enhancer 1 (MIEN1) is overexpressed in breast cancer and is a potential new therapeutic molecular target.

H. - B. Zhao, Zhang, X. - F., Wang, H. - B., and Zhang, M. - Z., “Migration and invasion enhancer 1 (MIEN1) is overexpressed in breast cancer and is a potential new therapeutic molecular target.”, Genet Mol Res, vol. 16, no. 1, 2017.